1
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
Condition(s):EphA2 Positive Malignant Glioma; CAR-T Cell ImmunotherapyLast Updated:August 16, 2017Completed
Immunotherapy: 4340 Clinical Trials, Page 1 of 434
Hide Studies Not Open or Pending
2
A Preliminary Study About Unexplained Recurrent Miscarriage and Repeated Implantation Failure Patients Treated With Low-dose Lymphocyte Immunotherapy
Condition(s):Unexplained Recurrent Miscarriage and Recurrent Implantation FailureLast Updated:April 11, 2018Completed
3
The Effects of Immunotherapy in the Nose
Condition(s):Rhinitis, Allergic, SeasonalLast Updated:November 15, 2013Completed
4
Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection
Condition(s):Hepatocellular Carcinoma; Malignant NeoplasmLast Updated:August 22, 2019Recruiting
5
Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma
Condition(s):Urinary Bladder NeoplasmLast Updated:January 11, 2018Recruiting
6
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
Condition(s):GD2 Positive Glioma; CAR-T Cell ImmunotherapyLast Updated:August 17, 2017Completed
7
CAR-T Cell Immunotherapy for HCC Targeting GPC3
Condition(s):GPC3 Positive Hepatocellular Carcinoma; CAR-T Cell ImmunotherapyLast Updated:August 16, 2017Completed
8
Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 19, 2018Recruiting
9
Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis
Condition(s):Atopic Dermatitis; Effects of ImmunotherapyLast Updated:January 17, 2019Active, not recruiting
10
A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE
Condition(s):CancerLast Updated:June 18, 2019Not yet recruiting